Heterocyclic compounds and their use in the treatment of mycobacterial infections

EP4727950A1Pending Publication Date: 2026-04-22GLAXOSMITHKLINE INTPROP DEV LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
GLAXOSMITHKLINE INTPROP DEV LTD
Filing Date
2024-06-13
Publication Date
2026-04-22

Smart Images

  • Figure IMGF000003_0001
    Figure IMGF000003_0001
  • Figure IMGF000003_0002
    Figure IMGF000003_0002
  • Figure IMGF000004_0001
    Figure IMGF000004_0001
Patent Text Reader

Abstract

The invention relates to compounds or pharmaceutically acceptable salts thereof, compositions containing them, including combinations with at least one additional therapeutic agent, and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by a mycobacterium, such as tuberculosis.
Need to check novelty before this filing date? Find Prior Art